First Financial Corp Evolus, Inc. Transaction History

First Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$3.53 - $6.17 $6,354 - $11,106	-1,800 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$3.53 - $12.21 $1,588 - $5,494	450 Added 33.33%	1,800 $7,000
Q2 2019 Jul 15, 2019	BUY	$13.19 - $28.36 $4,616 - $9,926	350 Added 35.0%	1,350 $20,000
Q4 2018 Jan 15, 2019	BUY	$10.57 - $19.29 $4,228 - $7,716	400 Added 66.67%	1,000 $12,000
Q3 2018 Oct 16, 2018	BUY	$17.31 - $29.82 $6,923 - $11,928	400 Added 200.0%	600 $11,000
Q2 2018 Jul 12, 2018	BUY	$6.85 - $38.49 $1,370 - $7,698	200 New	200 $6,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

Stay updated on First Financial Corp with notifications on news.